Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
about
Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edemaTransfer of single dose of intravitreal injection of ranibizumab and bevacizumab into milk of sheepAflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases.Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.Injectable Chemically Crosslinked Hydrogel for the Controlled Release of Bevacizumab in Vitreous: A 6-Month In Vivo StudyProfile of conbercept in the treatment of neovascular age-related macular degeneration.A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy.Intraocular pharmacokinetics of intravitreal vascular endothelial growth factor-Trap in a rabbit model.Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells.Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.Serum levels of intravitreal bevacizumab after vitrectomy, lensectomy and non-surgical controls.Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes.Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF.Recent perspectives on the delivery of biologics to back of the eye.Small-animal PET demonstrates brain metabolic change after using bevacizumab in a rat model of cerebral ischemic injury.Sudden visual loss in the untreated eye of a patient with neovascular glaucoma following an intravitreal bevacizumab injection: A case report.Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration.Stanniocalcin-1 rescued photoreceptor degeneration in two rat models of inherited retinal degeneration.Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution.The efficacy and safety of aflibercept and conbercept in diabetic macular edema
P2860
Q33759212-08486DA0-22B3-45F6-8B9D-78B7FC99F8B5Q33912465-C0765C5B-A28F-4430-AF73-1EA2960FB1D7Q34658699-8AA64D15-2F0F-4DFA-B705-D3FDC8B9020CQ34740219-7AFFE4F9-65AD-433A-89AD-3F0F8073998AQ35166714-08BBAE60-3CB3-4D22-B053-F9462193AE0DQ35541714-8793E978-9EE7-4D11-A991-8EC0134D12DBQ36731129-B24A2EA2-8951-42A3-AC23-074FD63AEF5DQ36752250-11F0FD1B-2FE0-4F74-B3E7-B8CFBA7B9E56Q37070754-496D1FB7-EEDC-4D3F-B10E-174A8CB20F61Q37133086-A1C46C82-0F81-4974-A513-9F5B67138BB2Q37455178-7A7FFB62-CCF8-49ED-9031-C9561B74DF3AQ37549985-AB64CF8F-824E-4742-ABEF-80E1E8BD09ABQ38183850-6D3C3B89-C851-4445-BECA-9EF81D880EA7Q38940171-940C8967-C575-4FCB-88B4-37C301C8CA79Q41458017-AE6A438A-44CE-401E-BCC3-9CEE3EF45114Q41837052-9E57146B-9A34-4DED-8F70-43F386F3C8E3Q41925040-7F127F55-0301-488A-87CF-1E8E41952DC4Q41974923-69188139-4B6E-4977-B653-56A64D5A9899Q41975515-EBC34D01-6B7A-4028-BBE8-FFE66F7BAFDBQ58562047-4C52BA2B-9233-411F-A2EB-11ACF758B424
P2860
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
@ast
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
@en
type
label
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
@ast
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
@en
prefLabel
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
@ast
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
@en
P2093
P2860
P356
P1476
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
@en
P2093
Alkistis Pantopoulou
Angelos I Sinapis
Christos I Sinapis
Despoina Perrea
Dimitrios I Sinapis
Efstratios Patsouris
George D Agrogiannis
Stamatis E Theocharis
Stefanos Baltatzis
P2860
P304
P356
10.2147/OPTH.S19555
P407
P577
2011-05-24T00:00:00Z